Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Intangibles (2020 - 2022)

Edesa Biotech's Intangibles history spans 4 years, with the latest figure at $2.5 million for Q1 2022.

  • For Q1 2022, Intangibles changed N/A year-over-year to $2.5 million; the TTM value through Mar 2022 reached $2.5 million, changed N/A, while the annual FY2021 figure was $2.4 million, 100.0% down from the prior year.
  • Intangibles for Q1 2022 was $2.5 million at Edesa Biotech, down from $2529.5 billion in the prior quarter.
  • Across five years, Intangibles topped out at $2529.5 billion in Q3 2020 and bottomed at $2.4 million in Q3 2021.
  • The 3-year median for Intangibles is $2.5 million (2020), against an average of $843.2 billion.
  • The largest YoY upside for Intangibles was 4.03% in 2021 against a maximum downside of 100.0% in 2021.
  • A 3-year view of Intangibles shows it stood at $2529.5 billion in 2020, then changed by 0.0% to $2529.5 billion in 2021, then plummeted by 100.0% to $2.5 million in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Intangibles are $2.5 million (Q1 2022), $2529.5 billion (Q4 2021), and $2.4 million (Q3 2021).